Young-donor plasma exchange
1 paper1 finding
- 1 lab in 1 country
- Funders: Nasjonalforeningen for Folkehelsen and 1 more
- 1 of 1 finding with company ties
- Human trial1
Associations
1Plasma exchange adverse events
no changein humans1
1 study
Plasma exchange adverse events
no changein humans1
Young-donor plasma exchange is associated with plasma exchange adverse events in humans.
“The procedures were feasible, and the adverse events observed were consistent with known risks of plasma exchange, supporting further investigation of treatment efficacy in a larger controlled trial.”
Human trialin patients with mild cognitive impairment with biomarker evidence of AD16 to 26 Ln = 12
GeroScience23 Jul 2026
Latest
1 in 12 monthsGeroScience
Interstitial fluid rejuvenation through young-donor plasma exchange in cognitively impaired patients: a pilot safety and feasibility study
Non-randomised trial in 12 peopleInterventions